Clonal lineage and biofilm growth shape cefiderocol activity in Acinetobacter baumannii from oncology patients
Frontiers in Cellular and Infection Microbiology · 14.04.2026 · 16
DOI: 10.3389/fcimb.2026.1788718 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, online erschienen am 14.04.2026. Verfasst von Ilaria Cavallo und 11 weiteren Autor:innen. Beteiligte Einrichtung: Microbiology and Virology, San Gallicano Dermatological Institute, IRCCS, Rome, Italy. Hauptthemen laut MEDLINE: Cephalosporins, Acinetobacter baumannii, Biofilms, Anti-Bacterial Agents. Die Arbeit nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Acinetobacter baumannii is a leading cause of healthcare-associated infections in immunocompromised patients and frequently exhibits multidrug resistance. Cefiderocol, a siderophore cephalosporin, is among the few remaining therapeutic options for infections caused by carbapenem-resistant A. baumannii (CRAB); however, its activity may differ by clonal lineage and can be further compromised in the biofilm state. This study investigates genomic features and cefiderocol efficacy against planktonic and biofilm-associated forms of oncology-derived A. baumannii isolates.
Methods
Twenty-five non-duplicate, consecutive clinical isolates of A. baumannii from oncology patients underwent whole-genome sequencing and multilocus sequence typing. Cefiderocol activity was quantified in planktonic and biofilm-associated states using minimum bactericidal concentration (MBC) and minimum biofilm eradication concentration (MBEC) assays.
Results
Ten sequence types were identified, with the high-risk sequence type 2 (ST2) clone accounting for 56% (14/25) of isolates. ST2 strains showed significantly higher resistance to aminoglycosides, carbapenems, and fluoroquinolones than non-ST2 (NST) strains. The carbapenemase gene bla OXA−23 was detected exclusively in ST2. Colistin and cefiderocol were the most active agents overall. ST2 strains showed higher cefiderocol MBC values than NST strains. However, avibactam significantly reduced cefiderocol MBC in ST2, consistent with class D β-lactamases activity. ST2 and NST isolates exhibited comparable distributions of iron acquisition genes and similar CAS-detected siderophore activity under the assay conditions tested. Cefiderocol activity was significantly reduced in biofilms relative to planktonic cells (median MBEC 2 µg/ml versus median MBC 0.5 µg/ml). NST exhibited higher MBEC/MBC ratios than ST2 isolates, indicating greater biofilm-associated tolerance to cefiderocol.
Discussion
Collectively, these data associate the predominance of oncology-derived ST2 with bla OXA-23 carriage and higher cefiderocol bactericidal thresholds and show that cefiderocol activity is consistently reduced in the biofilm state. Future studies integrating functional measures of iron acquisition and β-lactamase activity will be needed to define the determinants of cefiderocol efficacy across lineages and growth states.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Microbiology and Virology, San Gallicano Dermatological Institute, IRCCS, Rome, Italy.
- Department of Biology and Biotechnology "C. Darwin", Sapienza University of Rome, Rome, Italy.
Zitieren
APA
Cavallo, I., Sivori, F., Truglio, M., Francalancia, M., Abril, E., Fabrizio, G., Petrolo, S., Maione, F., Prignano, G., Mastrofrancesco, A., Pimpinelli, F., & Di Domenico, E. G. (2026). Clonal lineage and biofilm growth shape cefiderocol activity in Acinetobacter baumannii from oncology patients. Frontiers in Cellular and Infection Microbiology, 16. https://doi.org/10.3389/fcimb.2026.1788718
Vancouver
Cavallo I, Sivori F, Truglio M, Francalancia M, Abril E, Fabrizio G, et al. Clonal lineage and biofilm growth shape cefiderocol activity in Acinetobacter baumannii from oncology patients. Frontiers in Cellular and Infection Microbiology. 2026;16. doi:10.3389/fcimb.2026.1788718
BibTeX
@article{Cavallo2026,
author = {Cavallo, Ilaria and Sivori, Francesca and Truglio, Mauro and Francalancia, Massimo and Abril, Elva and Fabrizio, Giorgia and Petrolo, Sara and Maione, Francesca and Prignano, Grazia and Mastrofrancesco, Arianna and Pimpinelli, Fulvia and Di Domenico, Enea Gino},
title = {Clonal lineage and biofilm growth shape cefiderocol activity in Acinetobacter baumannii from oncology patients},
journal = {Frontiers in Cellular and Infection Microbiology},
year = {2026},
volume = {16},
doi = {10.3389/fcimb.2026.1788718}
}
EUVIMED